PRECLUDE study of Caisson TMVI system concludes

LivaNova has announced the conclusion of the PRELUDE feasibility study for its Caisson transcatheter mitral valve implantation (TMVI) system. The PRELUDE first-in-human study evaluated...

Boston Scientific closes acquisition of Claret Medical

Boston Scientific has announced that it has recently closed its acquisition of Claret Medical, which developed and commercialised the Sentinel cerebral embolic protection system—the...

On the fence result for initial CMS vote about TAVI volume requirements

A Medicare Evidence Development and Coverage Advisory Committee (MEDCAC) panel of the Centers for Medicare & Medicaid Services (CMS), according to Medscape, has not...

Abbott launches trial of its Tendyne transcatheter mitral valve implantation device

Abbott has initiated a pivotal clinical study in the USA of its Tendyne transcatheter mitral valve implantation (TMVI) system for the treatment of mitral...

Ron Waksman

Justin Davies

Francesco Maisano

(Visited 1,755 times, 3 visits today)